Sumitomo Mitsui Trust Group
IONS icon

Sumitomo Mitsui Trust Group’s Ionis Pharmaceuticals IONS Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.15M Sell
81,876
-11,875
-13% -$937K ﹤0.01% 705
2025
Q4 		$7.42M Sell
93,751
-21,021
-18% -$1.58M ﹤0.01% 703
2025
Q3 		$7.51M Sell
114,772
-24,967
-18% -$1.22M ﹤0.01% 698
2025
Q2 		$5.52M Sell
139,739
-2,694
-2% -$88.2K ﹤0.01% 710
2025
Q1 		$4.3M Sell
142,433
-14,224
-9% -$466K ﹤0.01% 744
2024
Q4 		$5.48M Sell
156,657
-39,457
-20% -$1.47M ﹤0.01% 739
2024
Q3 		$7.86M Sell
196,114
-3,117
-2% -$145K 0.01% 730
2024
Q2 		$9.5M Sell
199,231
-21,030
-10% -$863K 0.01% 711
2024
Q1 		$9.55M Sell
220,261
-32,198
-13% -$1.53M 0.01% 772
2023
Q4 		$12.8M Sell
252,459
-40,014
-14% -$1.92M 0.01% 753
2023
Q3 		$13.3M Sell
292,473
-3,659
-1% -$151K 0.01% 750
2023
Q2 		$12.2M Sell
296,132
-1,337
-0.4% -$51.4K 0.01% 772
2023
Q1 		$10.6M Sell
297,469
-39,263
-12% -$1.47M 0.01% 782
2022
Q4 		$12.7M Sell
336,732
-100,444
-23% -$4.22M 0.01% 769
2022
Q3 		$19.3M Sell
437,176
-30,940
-7% -$1.3M 0.02% 706
2022
Q2 		$17.3M Sell
468,116
-131,500
-22% -$4.96M 0.01% 742
2022
Q1 		$22.2M Sell
599,616
-6,286
-1% -$206K 0.01% 711
2021
Q4 		$18.4M Sell
605,902
-79,758
-12% -$2.51M 0.01% 721
2021
Q3 		$23M Buy
685,660
+161,334
+31% +$6.08M 0.01% 694
2021
Q2 		$20.9M Sell
524,326
-376,975
-42% -$14.8M 0.01% 724
2021
Q1 		$40.5M Buy
901,301
+136,617
+18% +$7.62M 0.03% 601
2020
Q4 		$43.2M Buy
764,684
+25,867
+4% +$1.29M 0.03% 577
2020
Q3 		$35.1M Sell
738,817
-46,612
-6% -$2.59M 0.02% 586
2020
Q2 		$46.3M Sell
785,429
-135,758
-15% -$7.55M 0.03% 516
2020
Q1 		$43.6M Sell
921,187
-48,996
-5% -$2.73M 0.04% 474
2019
Q4 		$58.6M Buy
970,183
+104,720
+12% +$6.24M 0.05% 418
2019
Q3 		$51.9M Buy
865,463
+60,363
+7% +$3.93M 0.05% 431
2019
Q2 		$51.7M Buy
805,100
+629,275
+358% +$44.5M 0.05% 424
2019
Q1 		$14.3M Buy
+175,825
New +$11.3M 0.01% 673
2016
Q3 		– Sell
-329,758
Closed -$7.68M – 867
2016
Q2 		$7.68M Buy
329,758
+4,900
+2% +$158K 0.01% 640
2016
Q1 		$13.2M Buy
324,858
+21,230
+7% +$862K 0.02% 605
2015
Q4 		$18.6M Sell
303,628
-11,537
-4% -$623K 0.03% 542
2015
Q3 		$12.7M Sell
315,165
-255
-0.1% -$13.2K 0.02% 604
2015
Q2 		$18.2M Buy
315,420
+18,893
+6% +$1.2M 0.03% 568
2015
Q1 		$18.9M Buy
+296,527
New +$20.1M 0.03% 550

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group's IONS Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Ionis Pharmaceuticals (IONS) stake by 13% in Q1 2026, selling an estimated $937K and leaving 81,876 shares worth $6.15M. The position accounts for ﹤0.01% of the portfolio, ranked #705.

Sumitomo Mitsui Trust Group first reported a position in IONS in Q1 2015 and has held it in 35 quarters since. The position peaked at $58.6M in Q4 2019. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 81,876 shares of Ionis Pharmaceuticals worth $6.15M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 11,875 Ionis Pharmaceuticals shares in Q1 2026, an estimated $937K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #705 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 35 quarters since.
  • Sumitomo Mitsui Trust Group's Ionis Pharmaceuticals position peaked at $58.6M in Q4 2019.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.